Obstructive Lung Disease Market Analysis: Trends, Challenges, and Opportunities

0
218

Obstructive Lung Disease Market Highlights

The obstructive lung disease market Size was valued at USD 23.84 Billion in 2023. The Global Obstructive Lung Disease industry is projected to grow from USD 24.32 Billion in 2024 to USD 52.16 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.12% during the forecast period (2024 - 2032).

The use of drugs has emerged as an effective solution for the treatment of COPD and asthma, which largely contributes to the growth of the global obstructive lung disease market. The market is driven by the growing COPD and asthmatic patient population, as well as the FDA approval for novel products and its wide acceptance. Increasing government initiatives to control COPD and asthma further, fuel the growth of this market.

Due to the rising instances of COPD across the globe, it has become indispensable for organizations to offer promising healthcare solutions to reduce health complications. With a considerable part of population being infected by the disease, renowned COPD drug manufacturers are facing the need to reduce inflammation and improve patient health outcomes.

Regional Analysis

Global obstructive lung disease consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

North America together dominates the gloabal asthma and COPD market followed by the European market. Rising prevalence of asthma and COPD due to pollution, changing lifestyle, and the entry of generic and novel therapies in the market.

Asia Pacific is anticipated to be the fastest growing market over the forecast period. Emerging economies such India, China due to industrialization, demographic changes, and urbanization are witnessing increased levels of pollution, thus favoring the rising prevalence of asthma and COPD population.

Segmentation

The obstructive lung disease is segmented on the basis of disease type, product type, drug class, route of administration and end-users.

On the basis of disease type, the market is segmented into asthma, bronchiectasis, bronchitis and chronic obstructive pulmonary disease (COPD), and others 

On the basis of product type, market is segmented into inhalers, and nebulizers. Inhalers are divided into Drug Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs). Moreover, nebulizers are divided into compressor nebulizers, ultrasonic nebulizers, and mesh nebulizers

On the basis of drug class, the market is segmented into combination drugs, leukotriene antagonists (LTA), inhaled corticosteroids (ICS), anticholinergics, short acting beta agonists (SABA), long-acting beta agonists (LABA), and others. Furthermore, the combination products are divided into seretide/advair, symbicort, relvar/breo ellipta, flutiform, dulera, and others. Leukotriene Antagonists (LTA) is divided into singulair and others. Inhaled Corticosteroids (ICS) is divided into qvar, pulmicort, aerospan, flovent, and others. Anticholinergics is divided into Spiriva and Others. Short Acting Beta Agonists (SABA) is divided into proair, ventolin, and others.

On the basis of route of administration, market is segmented into oral, inhaler, intravenous, subcutaneous, and others

On the basis of end-user, the market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.

Key Players

Some of the key obstructive lung disease market players are GlaxoSmithKline (GSK) (U.K), Novartis AG (Switzerland), Merck & Co. (U.S), Abbott Laboratories (U.S), Boehringer Ingelheim (Germany), AstraZeneca (U.K), Roche Holding AG (Switzerland), Teva Pharmaceutical Industries (Israel), Vectura Group (U.K), Pfizer Inc. (U.S), Mylan (U.S.), Aerovance Inc. (U.S.), Alkermes Inc. (U.S.), Almirall SA. (U.S.), Genentech Inc. (U.S.), Sepracor, Inc. (U.S.), Skyepharma plc (U.S.).

For more information visit at MarketResearchFuture

Related Report

Stem Cell Reconstructive Market

Medicated Personal Care Products Market

Brachytherapy Market

Urology Devices Market

Nanomedical Devices Market

Neuropsychiatric Disorders and Treatment Market

Anesthesia Delivery Devices Market

 

البحث
الأقسام
إقرأ المزيد
الألعاب
Unlocking Cole Palmer's TOTS Card in FC 24: A Complete Guide
Introduction About Cole Palmer Cole Jermaine Palmer, born on the 6th of May, 2002, is...
بواسطة Xtameem Xtameem 2024-05-01 04:22:06 0 748
أخرى
Solid Control Equipment Market Trend and Global Demand 2023 to 2029
The Solid Control Equipment Market report offers qualitative and quantitative insights as...
بواسطة Snehal Biraje 2023-11-10 04:52:21 0 2كيلو بايت
Networking
India Electric Vehicle Market Size, Trends, and Growth Outlook 2032
India’s Electric Vehicle (EV) Market in India Overview: India’s electric vehicle (EV)...
بواسطة Bondjoe Joe 2024-10-15 09:28:02 0 178
أخرى
It Asset Disposition Market to Grow Immensely at a CAGR of 7.60% From 2024 To 2033
According to Custom Market Insights (CMI), The Global IT Asset Disposition Market size...
بواسطة Trisha Jadhav 2024-09-23 12:55:05 0 263
أخرى
Collagen Supplements Market Size, Companies, Gross Margin with Regional Growth, Forecast
Market Forecast Global Collagen Supplements Market size is projected to be valued at USD 3.2...
بواسطة Daniel Disosa 2022-10-29 18:30:05 0 2كيلو بايت